299 related articles for article (PubMed ID: 17003108)
1. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.
Karamboulas C; Dakubo GD; Liu J; De Repentigny Y; Yutzey K; Wallace VA; Kothary R; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4315-21. PubMed ID: 17003108
[TBL] [Abstract][Full Text] [Related]
2. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage.
Karamboulas C; Swedani A; Ward C; Al-Madhoun AS; Wilton S; Boisvenue S; Ridgeway AG; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4305-14. PubMed ID: 17038545
[TBL] [Abstract][Full Text] [Related]
3. Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells.
Skerjanc IS; Petropoulos H; Ridgeway AG; Wilton S
J Biol Chem; 1998 Dec; 273(52):34904-10. PubMed ID: 9857019
[TBL] [Abstract][Full Text] [Related]
4. Nkx2-5 activity is essential for cardiomyogenesis.
Jamali M; Rogerson PJ; Wilton S; Skerjanc IS
J Biol Chem; 2001 Nov; 276(45):42252-8. PubMed ID: 11526122
[TBL] [Abstract][Full Text] [Related]
5. Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro.
Voronova A; Al Madhoun A; Fischer A; Shelton M; Karamboulas C; Skerjanc IS
Nucleic Acids Res; 2012 Apr; 40(8):3329-47. PubMed ID: 22199256
[TBL] [Abstract][Full Text] [Related]
6. Foxh1 is essential for development of the anterior heart field.
von Both I; Silvestri C; Erdemir T; Lickert H; Walls JR; Henkelman RM; Rossant J; Harvey RP; Attisano L; Wrana JL
Dev Cell; 2004 Sep; 7(3):331-45. PubMed ID: 15363409
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling induces cardiomyogenesis in P19 cells.
Gianakopoulos PJ; Skerjanc IS
J Biol Chem; 2005 Jun; 280(22):21022-8. PubMed ID: 15793308
[TBL] [Abstract][Full Text] [Related]
8. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development.
Takeuchi JK; Mileikovskaia M; Koshiba-Takeuchi K; Heidt AB; Mori AD; Arruda EP; Gertsenstein M; Georges R; Davidson L; Mo R; Hui CC; Henkelman RM; Nemer M; Black BL; Nagy A; Bruneau BG
Development; 2005 May; 132(10):2463-74. PubMed ID: 15843409
[TBL] [Abstract][Full Text] [Related]
9. Purkinje fibers of the avian heart express a myogenic transcription factor program distinct from cardiac and skeletal muscle.
Takebayashi-Suzuki K; Pauliks LB; Eltsefon Y; Mikawa T
Dev Biol; 2001 Jun; 234(2):390-401. PubMed ID: 11397008
[TBL] [Abstract][Full Text] [Related]
10. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.
Edmondson DG; Lyons GE; Martin JF; Olson EN
Development; 1994 May; 120(5):1251-63. PubMed ID: 8026334
[TBL] [Abstract][Full Text] [Related]
11. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes.
Swanson BJ; Jäck HM; Lyons GE
Mol Immunol; 1998 Jun; 35(8):445-58. PubMed ID: 9798649
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects.
Kodo K; Nishizawa T; Furutani M; Arai S; Ishihara K; Oda M; Makino S; Fukuda K; Takahashi T; Matsuoka R; Nakanishi T; Yamagishi H
Circ J; 2012; 76(7):1703-11. PubMed ID: 22498567
[TBL] [Abstract][Full Text] [Related]
13. Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells.
Skerjanc IS; Wilton S
FEBS Lett; 2000 Apr; 472(1):53-6. PubMed ID: 10781804
[TBL] [Abstract][Full Text] [Related]
14. Cooperative interaction of Nkx2.5 and Mef2c transcription factors during heart development.
Vincentz JW; Barnes RM; Firulli BA; Conway SJ; Firulli AB
Dev Dyn; 2008 Dec; 237(12):3809-19. PubMed ID: 19035347
[TBL] [Abstract][Full Text] [Related]
15. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
17. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
[TBL] [Abstract][Full Text] [Related]
18. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development.
Wang DZ; Valdez MR; McAnally J; Richardson J; Olson EN
Development; 2001 Nov; 128(22):4623-33. PubMed ID: 11714687
[TBL] [Abstract][Full Text] [Related]
19. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
Ma K; Chan JK; Zhu G; Wu Z
Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
[TBL] [Abstract][Full Text] [Related]
20. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
Ridgeway AG; Wilton S; Skerjanc IS
J Biol Chem; 2000 Jan; 275(1):41-6. PubMed ID: 10617583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
